Sandset PM - Search Results

1

Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin.

Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO. Kostovski E, et al. Among authors: sandset pm. Spinal Cord. 2015 Apr;53(4):285-90. doi: 10.1038/sc.2014.243. Epub 2015 Feb 3. Spinal Cord. 2015. PMID: 25644388 Free PMC article. Clinical Trial.

2

The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.

Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM. Høibraaten E, et al. Among authors: sandset pm. Thromb Haemost. 2001 May;85(5):775-81. Thromb Haemost. 2001. PMID: 11372667 Clinical Trial.

3

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.

Høibraaten E, Mowinckel MC, de Ronde H, Bertina RM, Sandset PM. Høibraaten E, et al. Among authors: sandset pm. Br J Haematol. 2001 Nov;115(2):415-20. doi: 10.1046/j.1365-2141.2001.03111.x. Br J Haematol. 2001. PMID: 11703344 Free article. Clinical Trial.

4

Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia.

Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM. Iversen PO, et al. Among authors: sandset pm. Br J Haematol. 2002 Dec;119(4):1011-6. doi: 10.1046/j.1365-2141.2002.03953.x. Br J Haematol. 2002. PMID: 12472582 Free article.

5

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.

Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM. Dahm A, et al. Among authors: sandset pm. Blood. 2003 Jun 1;101(11):4387-92. doi: 10.1182/blood-2002-10-3188. Epub 2003 Jan 30. Blood. 2003. PMID: 12560220 Free article.

6

The ability of three global plasma assays to recognize thrombophilia.

Andresen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM. Andresen MS, et al. Among authors: sandset pm. Thromb Res. 2004;113(6):411-7. doi: 10.1016/j.thromres.2004.05.002. Thromb Res. 2004. PMID: 15226097 Clinical Trial.

7

A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI).

Dahm AE, Andersen TO, Rosendaal F, Sandset PM. Dahm AE, et al. Among authors: sandset pm. J Thromb Haemost. 2005 Apr;3(4):651-8. doi: 10.1111/j.1538-7836.2005.01237.x. J Thromb Haemost. 2005. PMID: 15842349 Free article.

8

Determinants of the APTT- and ETP-based APC sensitivity tests.

de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM. de Visser MC, et al. Among authors: sandset pm. J Thromb Haemost. 2005 Jul;3(7):1488-94. doi: 10.1111/j.1538-7836.2005.01430.x. J Thromb Haemost. 2005. PMID: 15978106 Free article.

9

Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured.

Dahm AE, Iversen PO, Hjeltnes N, Sandset PM. Dahm AE, et al. Among authors: sandset pm. Thromb Res. 2006;118(2):281-7. doi: 10.1016/j.thromres.2005.07.021. Epub 2005 Aug 31. Thromb Res. 2006. PMID: 16139333

10

Angiogenesis and hemostasis in hematological neoplasias.

Negaard H, Dahm A, Sandset PM, Iversen PO, Østenstad B. Negaard H, et al. Among authors: sandset pm. Curr Drug Targets. 2005 Sep;6(6):683-99. doi: 10.2174/1389450054863699. Curr Drug Targets. 2005. PMID: 16178801 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page